Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
The Supreme Court handed down two wins and a loss.
The Supreme Court struck down a Louisiana law that would have shuttered most abortion clinics.
Here is how AIDS service organizations are responding to COVID-19.
New research sheds light on HIV among transgender men and women
A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”
By recording such details, clinicians can aid in improving LGBTQIA+ health disparities, argues a researcher.
Ashlie Jacob Pollard helps the Attic Youth Center provide health and wellness information and a sense of community.
Proposed legislation will address the harms of current laws.
NTHTD is a day to recognize importance of routine HIV testing, status awareness and continued focus.
A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.
Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.
Black queer men of MOBI talk about it all—including OnlyFans, HIV and adult films—in this artful digital video series.
Free virtual sessions will run from June through October.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.